Logo image
Bypass and Flow Reduction for Complex Basilar and Vertebrobasilar Junction Aneurysms
Journal article   Peer reviewed

Bypass and Flow Reduction for Complex Basilar and Vertebrobasilar Junction Aneurysms

M. Yashar S. Kalani, Joseph M. Zabramski, Peter Nakaji and Robert F. Spetzler
Neurosurgery, Vol.72(5), pp.763-775
05/01/2013
PMID: 23334279

Abstract

Clinical Neurology Life Sciences & Biomedicine Neurosciences & Neurology Science & Technology Surgery
BACKGROUND: Giant aneurysms of the vertebral and basilar arteries are formidable lesions to treat. OBJECTIVE: To evaluate the long-term outcomes of patients with vertebrobasilar aneurysms treated with extracranial-intracranial bypass and flow reduction. METHODS: We retrospectively reviewed a prospective database of aneurysms cases treated between December 1993 and August 2011. RESULTS: Eleven patients (8 male, 3 female) with 12 aneurysms were treated. There were 3 basilar apex aneurysms, 2 aneurysms of the basilar trunk, and 7 vertebrobasilar junction aneurysms. There were 5 saccular and 7 fusiform aneurysms. All patients underwent extracranial-intracranial bypass and vessel occlusion. Flow was reversed or reduced by complete (n = 6) or partial occlusion of the basilar artery (n = 3) or by occlusion of the vertebral arteries distal to the posterior inferior cerebellar artery (n = 3). Postoperatively (mean follow-up, 71.6 months; range, 4-228; median, 49 months), the bypass patency rate was 92.3% (12/13). The perioperative mortality rate for the initial treatment was 18.2% (2/11). In 4 cases, the aneurysms continued to grow and required further treatment; after re-treatment, 3 of these patients died. Of the initial 11 patients, 6 were treated successfully and 5 died. The mean preoperative modified Rankin Scale score was 2.1 (range, 1-3; median, 2). At last follow-up for all patients, the mean modified Rankin Scale score was 3.45 (range, 1-6; median, 3) and 2.5 (range, 1-4; median, 2.5) for the 6 long-term survivors. CONCLUSION: Vertebrobasilar aneurysms are challenging lesions with limited microsurgical or endovascular options. Despite aggressive surgical treatment, the long-term outcome remains poor for most patients.

Metrics

1 Record Views
56 readers on Mendeley

Details

Logo image